Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Pulmonary Hypertension, January 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 160 articles:
HTML format


 

Single Articles

  1. JOHNSON JN, Ivy DD
    The 2017 Seventh World Congress of Pediatric Cardiology & Cardiac Surgery: Week in Review: heart failure, transplantation, and pulmonary hypertension.
    Cardiol Young. 2017;27:2018-2022.
    Abstract    

    Abstract available

  2. CALCAIANU G, Calcaianu M, Gschwend A, Canuet M, et al
    EXPRESS: Hemodynamic profile of pulmonary hypertension (PH) in ARDS.
    Pulm Circ. 2017 Jan 1:2045893217753415. doi: 10.1177/2045893217753415.
    Abstract    



  3. MCLAUGHLIN VV, Jansa P, Nielsen-Kudsk JE, Halank M, et al
    Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.
    BMC Pulm Med. 2017;17:216.
    Abstract    

    Abstract available

  4. BERMEJO J, Yotti R, Garcia-Orta R, Sanchez-Fernandez PL, et al
    Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial.
    Eur Heart J. 2017 Dec 21. pii: 4769387. doi: 10.1093.
    Abstract    

    Abstract available

  5. MIURA M, Ikeda S, Yoshida T, Yamagata Y, et al
    Deeper S Wave in Lead V5 and Broader Extent of T Wave Inversions in the Precordial Leads are Clinically Useful Electrocardiographic Parameters for Predicting Pulmonary Hypertension.
    Int Heart J. 2017 Dec 27. doi: 10.1536.
    Abstract    

    Abstract available

  6. INAGAKI T, Terada J, Yahaba M, Kawata N, et al
    Heart Rate and Oxygen Saturation Change Patterns During 6-min Walk Test in Subjects With Chronic Thromboembolic Pulmonary Hypertension.
    Respir Care. 2017 Dec 26. pii: respcare.05788. doi: 10.4187/respcare.05788.
    Abstract    

    Abstract available

  7. ABELLEIRA R, Toubes ME, Alvarez Dobano JM, Valdes L, et al
    Pulmonary tumour thrombotic microangiopathy due to adenocarcinoma of the lung. A cause of pulmonary hypertension.
    Rev Port Pneumol (2006). 2017 Dec 23. pii: S2173-5115(17)30179.
    Abstract    



  8. ZHAI Z, Ota H, Staring M, Stolk J, et al
    Treatment Effect of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension Quantified by Automatic Comparative Imaging in Computed Tomography Pulmonary Angiography.
    Invest Radiol. 2017 Dec 22. doi: 10.1097/RLI.0000000000000441.
    Abstract    

    Abstract available

  9. YAMAGATA Y, Ikeda S, Nakata T, Yonekura T, et al
    Balloon pulmonary angioplasty is effective for treating peripheral-type chronic thromboembolic pulmonary hypertension in elderly patients.
    Geriatr Gerontol Int. 2017 Dec 26. doi: 10.1111/ggi.13224.
    Abstract    

    Abstract available

  10. KARASKOV AM, Bogachev-Prokophiev AV, Demidov DP, Afanasyev AV, et al
    [Perspective Directions in Management of Severe Group Two Pulmonary Hypertension].
    Kardiologiia. 2017;57:23-28.
    Abstract    

    Abstract available

  11. FARIA-URBINA M, Oliveira RKF, Agarwal M, Waxman AB, et al
    Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease.
    Lung. 2017 Dec 23. pii: 10.1007/s00408-017-0081.
    Abstract    

    Abstract available

  12. OKADA S, Sugawara A, Yamagata S, Takeuchi S, et al
    Pulmonary Hypertension and Its Response to Treatment in a Patient With Kyphosis-related Alveolar Hypoventilation.
    Intern Med. 2017 Dec 21. doi: 10.2169/internalmedicine.9244.
    Abstract    

    Abstract available

  13. MARON BA, Brittain EL, Choudhary G, Gladwin MT, et al
    Redefining pulmonary hypertension.
    Lancet Respir Med. 2017 Dec 18. pii: S2213-2600(17)30498.
    Abstract    



  14. BAKER CD
    Biomarkers of pulmonary hypertension after preterm birth: The IMPROV study.
    Pediatr Pulmonol. 2017 Dec 21. doi: 10.1002/ppul.23929.
    Abstract    



  15. ASOSINGH K, Erzurum S
    EXPRESS: Mechanisms of Right Heart Disease in Pulmonary Hypertension.
    Pulm Circ. 2017 Jan 1:2045893217753121. doi: 10.1177/2045893217753121.
    Abstract    



  16. HARARI S
    Pulmonary hypertension: a paradigm for rare pulmonary diseases.
    Eur Respir Rev. 2017;26.
    Abstract    



  17. MADANI M, Ogo T, Simonneau G
    The changing landscape of chronic thromboembolic pulmonary hypertension management.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  18. CHAN SY, Rubin LJ
    Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice.
    Eur Respir Rev. 2017;26.
    Abstract    

    Abstract available

  19. SCHAFER M, Barker AJ, Kheyfets V, Stenmark KR, et al
    Helicity and Vorticity of Pulmonary Arterial Flow in Patients With Pulmonary Hypertension: Quantitative Analysis of Flow Formations.
    J Am Heart Assoc. 2017;6.
    Abstract    

    Abstract available

  20. JOHNS CS, Wild JM, Rajaram S, Swift AJ, et al
    Current and emerging imaging techniques in the diagnosis and assessment of pulmonary hypertension.
    Expert Rev Respir Med. 2017 Dec 20. doi: 10.1080/17476348.2018.1420478.
    Abstract    

    Abstract available

  21. WANG X, Cai X, Wang W, Jin Y, et al
    Effect of asiaticoside on endothelial cells in hypoxiainduced pulmonary hypertension.
    Mol Med Rep. 2018;17:2893-2900.
    Abstract    

    Abstract available

  22. LV TT, Wang P, Guan SY, Li HM, et al
    Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis.
    Ir J Med Sci. 2017 Dec 18. pii: 10.1007/s11845-017-1727.
    Abstract    

    Abstract available

  23. TRUONG QA, Bhatia HS, Szymonifka J, Zhou Q, et al
    A four-tier classification system of pulmonary artery metrics on computed tomography for the diagnosis and prognosis of pulmonary hypertension.
    J Cardiovasc Comput Tomogr. 2017 Dec 6. pii: S1934-5925(17)30259.
    Abstract    

    Abstract available

  24. BALKIN EM, Steurer MA, Delagnes EA, Zinter MS, et al
    Multicenter mortality and morbidity associated with pulmonary hypertension in the pediatric intensive care unit.
    Pulm Circ. 2018;8:2045893217745785.
    Abstract    

    Abstract available

  25. MEOLI DF, Su YR, Brittain E, Robbins I, et al
    EXPRESS: The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension.
    Pulm Circ. 2017 Jan 1:2045893217745019. doi: 10.1177/2045893217745019.
    Abstract    



  26. AKAGI S, Nakamura K, Sarashina T, Ejiri K, et al
    Progression of pulmonary artery dilatation in patients with pulmonary hypertension coexisting with a pulmonary artery aneurysm.
    J Cardiol. 2017 Dec 12. pii: S0914-5087(17)30326.
    Abstract    

    Abstract available

  27. SHAH M, Phillips MR, Quintana M, Stupp G, et al
    Echocardiography allows for analysis of pulmonary arterial flow in mice with congenital diaphragmatic hernia.
    J Surg Res. 2018;221:35-42.
    Abstract    

    Abstract available

  28. XU Y, Gu Q, Liu N, Yan Y, et al
    PPARgamma Alleviates Right Ventricular Failure Secondary to Pulmonary Arterial Hypertension in Rats.
    Int Heart J. 2017;58:948-956.
    Abstract    

    Abstract available

  29. BAGNATO GL, Ruggeri RM, Certo R, Cusma Piccione M, et al
    Serum thyroxine levels are associated with increased systolic pulmonary arterial pressure in systemic sclerosis.
    Clin Exp Rheumatol. 2017;35 Suppl 106:220.
    Abstract    



  30. RIED M, Neu R, Lehle K, Grosser C, et al
    Superior vasodilation of human pulmonary vessels by vardenafil compared with tadalafil and sildenafil: additive effects of bosentan.
    Interact Cardiovasc Thorac Surg. 2017;25:254-259.
    Abstract    

    Abstract available

  31. SALA V, Margaria JP, Murabito A, Morello F, et al
    Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).
    Curr Heart Fail Rep. 2017;14:187-196.
    Abstract    

    Abstract available

  32. TRINDADE M, Oigman W, Fritsch Neves M
    Potential Role of Endothelin in Early Vascular Aging.
    Curr Hypertens Rev. 2017;13:33-40.
    Abstract    

    Abstract available

  33. SINGH P, Seth A
    Indian Childhood Cirrhosis - A Forgotten Entity.
    Indian Pediatr. 2017;54:239-240.
    Abstract    



  34. MEDAROV BI, Jogani S, Sun J, Judson MA, et al
    Readdressing the entity of exercise pulmonary arterial hypertension.
    Respir Med. 2017;124:65-71.
    Abstract    

    Abstract available

  35. VANDECASTEELE E, Thevissen K, Melsens K, De Keyser F, et al
    Six-minute walk test in or out in evaluation of systemic sclerosis patients?
    Clin Exp Rheumatol. 2017;35 Suppl 106:122-129.
    Abstract    

    Abstract available

  36. BHAVE NM, Visovatti SH, Kulick B, Kolias TJ, et al
    Right atrial strain is predictive of clinical outcomes and invasive hemodynamic data in group 1 pulmonary arterial hypertension.
    Int J Cardiovasc Imaging. 2017;33:847-855.
    Abstract    

    Abstract available

  37. AVAZMOHAMMADI R, Hill MR, Simon MA, Zhang W, et al
    A novel constitutive model for passive right ventricular myocardium: evidence for myofiber-collagen fiber mechanical coupling.
    Biomech Model Mechanobiol. 2017;16:561-581.
    Abstract    

    Abstract available

  38. RAMJUG S, Hussain N, Hurdman J, Elliot CA, et al
    Long-term outcomes of domiciliary intravenous iloprost in idiopathic and connective tissue disease-associated pulmonary arterial hypertension.
    Respirology. 2017;22:372-377.
    Abstract    

    Abstract available

  39. NOGUCHI A, Kato M, Kono M, Ohmura K, et al
    Bi-ventricular interplay in patients with systemic sclerosis-associated pulmonary arterial hypertension: Detection by cardiac magnetic resonance.
    Mod Rheumatol. 2017;27:481-488.
    Abstract    

    Abstract available

  40. PAPAIOANNOU AI, Kostikas K, Manali ED, Papadaki G, et al
    Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract.
    Respir Med. 2016;117:14-26.
    Abstract    

    Abstract available

  41. HERINGLAKE M, Schon J, Pliet T, Haake N, et al
    Prevalence, Diagnosis, Perioperative Monitoring and Treatment of Right Ventricular Dysfunction and/or Pulmonary Arterial Hypertension in Cardiac Surgical Patients in Germany-A Postal Survey.
    Thorac Cardiovasc Surg. 2017;65:593-600.
    Abstract    

    Abstract available

  42. WU W, Li Y, Xu DQ
    Role of ROS/Kv/HIF Axis in the Development of Hypoxia-Induced Pulmonary Hypertension.
    Chin Med Sci J. 2017;32:253-259.
    Abstract    

    Abstract available

  43. TANIYAMA D, Kamata H, Miyamoto K, Mashimo S, et al
    Autopsy Findings in A Case of Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension.
    Am J Case Rep. 2017;18:1401-1406.
    Abstract    



  44. VERBELEN T, Van De Bruaene A, Cools B, Van Raemdonck D, et al
    Postoperative left ventricular function in different types of pulmonary hypertension: a comparative study.
    Interact Cardiovasc Thorac Surg. 2018 Jan 2. pii: 4782697.
    Abstract    

    Abstract available

  45. NAKANISHI H, Suenaga H, Uchiyama A, Kusuda S, et al
    Persistent pulmonary hypertension of the newborn in extremely preterm infants: a Japanese cohort study.
    Arch Dis Child Fetal Neonatal Ed. 2018 Jan 3. pii: archdischild-2017-313778.
    Abstract    

    Abstract available

  46. ASOSINGH K, Wanner N, Weiss K, Queisser K, et al
    Bone marrow transplantation prevents right ventricle disease in the caveolin-1-deficient mouse model of pulmonary hypertension.
    Blood Adv. 2017;1:526-534.
    Abstract    

    Abstract available

  47. LOW LYH, Sia CH, Lik-Wui Tay E, Loh JPY, et al
    Chronic thromboembolic pulmonary hypertension & homocysteinaemia.
    QJM. 2017 Dec 26. pii: 4775110. doi: 10.1093.
    Abstract    



  48. GALIE N, Manes A, Dardi F, Palazzini M, et al
    Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease.
    Eur Heart J. 2017 Dec 27. pii: 4780182. doi: 10.1093.
    Abstract    



  49. HOJO D, Murono K, Ishihara S, Kaneko M, et al
    Marked edema of colonic stoma after colectomy and severe pulmonary hypertension: Report of two cases.
    Clin Res Hepatol Gastroenterol. 2017 Dec 29. pii: S2210-7401(17)30094.
    Abstract    

    Abstract available

  50. MORIYAMA H, Murata M, Tsugu T, Kawakami T, et al
    The clinical value of assessing right ventricular diastolic function after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
    Int J Cardiovasc Imaging. 2017 Dec 30. pii: 10.1007/s10554-017-1296.
    Abstract    

    Abstract available

  51. EDRISS H, Selvan K, Denega T, Rodrigues T, et al
    The Complexity of Characteristics, Diagnoses and Treatment of Older Patients With Pulmonary Hypertension.
    Am J Med Sci. 2018;355:13-20.
    Abstract    

    Abstract available

  52. FAGAN KA
    Pulmonary Hypertension-Is It the Same Disease in Young Versus Older Patients?
    Am J Med Sci. 2018;355:1-2.
    Abstract    



  53. MORRISROE K, Stevens W, Huq M, Prior D, et al
    Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension.
    Arthritis Res Ther. 2017;19:122.
    Abstract    

    Abstract available

  54. XU XQ, Zhang HD, Jing ZC
    Reply to "Comment on direct bilirubin as predictor of severity and mortality in idiopathic pulmonary arterial hypertension".
    Int J Cardiol. 2017;239:36.
    Abstract    



  55. MONNERET D, Cracowski JL
    Comment on direct bilirubin as predictor of severity and mortality in idiopathic pulmonary arterial hypertension.
    Int J Cardiol. 2017;239:35.
    Abstract    



  56. BONTA DV, Aarsvold JN, Grant SF, Alazraki NP, et al
    Harmonic subtraction for evaluating right ventricle ejection fraction from planar equilibrium radionuclide angiography.
    Int J Cardiovasc Imaging. 2017;33:1857-1862.
    Abstract    

    Abstract available

  57. SEGURA-IBARRA V, Amione-Guerra J, Cruz-Solbes AS, Cara FE, et al
    Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension.
    Int J Pharm. 2017;524.
    Abstract    

    Abstract available

  58. HASCOET S, Fournier E, Jais X, Le Gloan L, et al
    Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study.
    Arch Cardiovasc Dis. 2017;110:303-316.
    Abstract    

    Abstract available

  59. MORRISROE K, Stevens W, Sahhar J, Rabusa C, et al
    Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme.
    Arthritis Res Ther. 2017;19:42.
    Abstract    

    Abstract available

  60. CHEN P, Huang Y, Fang Z, Hu X, et al
    [Clinical value of ADMA in patients with pulmonary arterial hypertension combination with congenital heart disease].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017;42:35-40.
    Abstract    

    Abstract available

  61. CHIA KS, Faux SG, Wong PK, Holloway C, et al
    Randomised controlled trial examining the effect of an outpatient exercise training programme on haemodynamics and cardiac MR parameters of right ventricular function in patients with pulmonary arterial hypertension: the ExPAH study protocol.
    BMJ Open. 2017;7:e014037.
    Abstract    

    Abstract available

  62. KASSIS H, Cherukuri K, Agarwal R, Kanwar M, et al
    Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    JACC Heart Fail. 2017;5:81-88.
    Abstract    

    Abstract available

  63. GIN-SING W
    Palliative care in pulmonary arterial hypertension.
    Curr Opin Support Palliat Care. 2017;11:7-11.
    Abstract    

    Abstract available

  64. BRUNI C, Praino E, Allanore Y, Distler O, et al
    Use of biologics and other novel therapies for the treatment of systemic sclerosis.
    Expert Rev Clin Immunol. 2017;13:469-482.
    Abstract    

    Abstract available

  65. CHENG XL, He JG, Liu ZH, Gu Q, et al
    The Value of the Electrocardiogram for Evaluating Prognosis in Patients with Idiopathic Pulmonary Arterial Hypertension.
    Lung. 2017;195:139-146.
    Abstract    

    Abstract available

  66. MASRI SC, Tedford RJ, Colvin MM, Leary PJ, et al
    Pulmonary Arterial Compliance Improves Rapidly After Left Ventricular Assist Device Implantation.
    ASAIO J. 2017;63:139-143.
    Abstract    

    Abstract available

  67. DESAI AV, Heneghan MB, Li Y, Bunin NJ, et al
    Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma.
    Bone Marrow Transplant. 2016 May 9. doi: 10.1038/bmt.2016.
    Abstract    

    Abstract available

  68. KEIR GJ, John Wort S, Kokosi M, George PM, et al
    Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization.
    Respirology. 2018 Jan 12. doi: 10.1111/resp.13250.
    Abstract    

    Abstract available

  69. IVARSSON B, Radegran G, Hesselstrand R, Kjellstrom B, et al
    Coping, social support and information in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A 2-year retrospective cohort study.
    SAGE Open Med. 2018;6:2050312117749159.
    Abstract    

    Abstract available

  70. LAZARO SALVADOR M, Escribano Subias P, Castro Fernandez A, Hernandez Simon P, et al
    Selection of the Best of 2017 in Pulmonary Hypertension.
    Rev Esp Cardiol (Engl Ed). 2018 Jan 8. pii: S1885-5857(17)30594.
    Abstract    




  71. [Research progress on the role of microRNAs in pulmonary hypertension].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45:1107-1111.
    Abstract    



  72. ZHU CX, Xiong W, Yang J, Chen HQ, et al
    [Obstetric outcome in pregnancy complained with pulmonary hypertension].
    Zhonghua Yi Xue Za Zhi. 2017;97:3711-3715.
    Abstract    

    Abstract available

  73. BEN BOUALLEGUE F, Vauchot F, Bourdon A, Benkiran M, et al
    RV function improvement following nitric oxide inhalation demonstrated by gated blood pool SPECT in a patient with primary pulmonary hypertension.
    J Nucl Cardiol. 2018 Jan 10. pii: 10.1007/s12350-017-1171.
    Abstract    



  74. SUGIYAMA K, Koizumi N, Ogino H
    Severe Compression of the Left Main Coronary Artery in a Patient with Chronic Thromboembolic Pulmonary Hypertension.
    Ann Thorac Cardiovasc Surg. 2018 Jan 10. doi: 10.5761/atcs.cr.17-00084.
    Abstract    

    Abstract available

  75. SPARROW CT, LaRue SJ, Schilling JD
    Intersection of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients on Left Ventricular Assist Device Support: Is There a Role for Pulmonary Vasodilators?
    Circ Heart Fail. 2018;11:e004255.
    Abstract    

    Abstract available

  76. KUANG MD, Wang J, Chen YQ
    [Role of cigarette smoke in the pathogenesis of pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2017;40:866-869.
    Abstract    



  77. DOMICO M, Ridout D, MacLaren G, Barbaro R, et al
    Extracorporeal Membrane Oxygenation for Pertussis: Predictors of Outcome Including Pulmonary Hypertension and Leukodepletion.
    Pediatr Crit Care Med. 2018 Jan 9. doi: 10.1097/PCC.0000000000001454.
    Abstract    

    Abstract available

  78. KWON W, Yang JH, Park TK, Chang SA, et al
    Impact of Balloon Pulmonary Angioplasty on Hemodynamics and Clinical Outcomes in Patients with Chronic Thromboembolic Pulmonary Hypertension: the Initial Korean Experience.
    J Korean Med Sci. 2018;33:e24.
    Abstract    

    Abstract available

  79. PAGNAMENTA A, Lador F, Azzola A, Beghetti M, et al
    Modern Invasive Hemodynamic Assessment of Pulmonary Hypertension.
    Respiration. 2018 Jan 9. pii: 000484942. doi: 10.1159/000484942.
    Abstract    

    Abstract available

  80. BUCHBINDER D, Montealegre Sanchez GA, Goldbach-Mansky R, Brunner H, et al
    Rash, Fever, and Pulmonary Hypertension in a 6-Year-Old Female.
    Arthritis Care Res (Hoboken). 2018 Jan 5. doi: 10.1002/acr.23506.
    Abstract    

    Abstract available

  81. KIM HD, Chun KJ, Choi S, Cho JR, et al
    Reversible pulmonary hypertension with unclear etiology associated with suspected viral infection.
    J Thorac Dis. 2017;9:E1074-E1078.
    Abstract    

    Abstract available

  82. MURAKI Y, Yamasaki M, Takeuchi H, Tohyama K, et al
    Fluorescent Imaging Analysis for Distribution of fluorescent dye labeled- or encapsulated- liposome in Monocrotaline-induced Pulmonary Hypertension model rat.
    Chem Pharm Bull (Tokyo). 2018 Jan 6. doi: 10.1248/cpb.c17-00811.
    Abstract    

    Abstract available

  83. FARIA URBINA M, Oliveira R, Segrera SA, Lawler L, et al
    EXPRESS: Impaired systemic oxygen extraction in treated exercise pulmonary hypertension: a new engine in an old car?
    Pulm Circ. 2018 Jan 1:2045893218755325. doi: 10.1177/2045893218755325.
    Abstract    



  84. MCCARTHY E, Ogawa MT, Hopper RK, Feinstein JA, et al
    EXPRESS: Central Line Replacement Following Infection Does Not Improve Reinfection Rates in Pediatric Pulmonary Hypertension Patients Receiving Intravenous Prostanoid Therapy.
    Pulm Circ. 2018 Jan 1:2045893218754886. doi: 10.1177/2045893218754886.
    Abstract    



  85. HOPE KD, Calderon Anyosa RJC, Wang Y, Montero AE, et al
    EXPRESS: Right Atrial Mechanics Provide Useful Insight in Pediatric Pulmonary Hypertension.
    Pulm Circ. 2018 Jan 1:2045893218754852. doi: 10.1177/2045893218754852.
    Abstract    



  86. WADA DT, de Padua AI, Lima Filho MO, Marin Neto JA, et al
    Use of computed tomography and automated software for quantitative analysis of the vasculature of patients with pulmonary hypertension.
    Radiol Bras. 2017;50:351-358.
    Abstract    

    Abstract available

  87. DE BOECK BW, Toma A, Kiencke S, Dehnert C, et al
    Altered Left Ventricular Geometry and Torsional Mechanics in High Altitude-Induced Pulmonary Hypertension: A Three-Dimensional Echocardiographic Study.
    J Am Soc Echocardiogr. 2018 Jan 3. pii: S0894-7317(17)30857.
    Abstract    

    Abstract available

  88. PEKTAS A, Olgunturk R, Kula S, Cilsal E, et al
    Biomarker and shear stress in secondary pediatric pulmonary hypertension
    Turk J Med Sci. 2017;47:1854-1860.
    Abstract    

    Abstract available

  89. FELDMAN J, Habib N, Radosevich J, Dutt M, et al
    Oral treprostinil in the treatment of pulmonary arterial hypertension.
    Expert Opin Pharmacother. 2017;18:1661-1667.
    Abstract    

    Abstract available

  90. VIZZA CD, Jansa P, Teal S, Dombi T, et al
    Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.
    BMC Cardiovasc Disord. 2017;17:239.
    Abstract    

    Abstract available

  91. RUDKOVSKAIA AA, Lo YC, Brady V, Costa J, et al
    A 49-Year-Old Man with Subacute Respiratory Failure and Interstitial Lung Opacities.
    Am J Case Rep. 2017;18:941-944.
    Abstract    

    Abstract available

  92. YILDIZ M, Sahin A, Behnes M, Akin I, et al
    An Expanding Role of Biomarkers in Pulmonary Arterial Hypertension.
    Curr Pharm Biotechnol. 2017;18:491-494.
    Abstract    

    Abstract available

  93. DEMETRIADES P, Aziz A, Condliffe R, Bowater SE, et al
    The use of Macitentan in Fontan circulation: a case report.
    BMC Cardiovasc Disord. 2017;17:131.
    Abstract    

    Abstract available

  94. VAN DER FEEN DE, Weij M, Smit-van Oosten A, Jorna LM, et al
    Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension.
    J Vis Exp. 2017;.
    Abstract    

    Abstract available

  95. PETER A, Fatykhova D, Kershaw O, Gruber AD, et al
    Localization and pneumococcal alteration of junction proteins in the human alveolar-capillary compartment.
    Histochem Cell Biol. 2017;147:707-719.
    Abstract    

    Abstract available

  96. CHANDRASEKHARAN P, Kozielski R, Kumar VH, Rawat M, et al
    Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach?
    Am J Perinatol. 2016.
    Abstract    

    Abstract available

  97. SCHAFER M, Ivy DD, Barker AJ, Kheyfets V, et al
    Characterization of CMR-derived haemodynamic data in children with pulmonary arterial hypertension.
    Eur Heart J Cardiovasc Imaging. 2017;18:424-431.
    Abstract    

    Abstract available

  98. MARTIANO D, Chevreaud O, Lam D, Cohen SY, et al
    ACUTE SEROUS RETINAL DETACHMENT IN IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION.
    Retin Cases Brief Rep. 2017;11:261-265.
    Abstract    

    Abstract available

  99. BOND AR, Iacobazzi D, Abdul-Ghani S, Ghorbel M, et al
    Changes in contractile protein expression are linked to ventricular stiffness in infants with pulmonary hypertension or right ventricular hypertrophy due to congenital heart disease.
    Open Heart. 2018;5:e000716.
    Abstract    

    Abstract available

  100. HONG C, Li JY, Chen RK, Liu CL, et al
    [Correlation between peripheral venous oxygen saturation and hemodynamic parameters in patients with pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2018;41:37-40.
    Abstract    

    Abstract available

  101. ARJAANS S, Zwart EAH, Ploegstra MJ, Bos AF, et al
    Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: A systematic review and meta-analysis.
    Paediatr Perinat Epidemiol. 2018 Jan 17. doi: 10.1111/ppe.12444.
    Abstract    

    Abstract available

  102. KAYALI S, Ertugrul I, Yoldas T, Kaya O, et al
    Sensitive Cardiac Troponins: Could They Be New Biomarkers in Pediatric Pulmonary Hypertension Due to Congenital Heart Disease?
    Pediatr Cardiol. 2018 Jan 16. pii: 10.1007/s00246-018-1811.
    Abstract    

    Abstract available

  103. SKJORTEN I, Hilde JM, Melsom MN, Hisdal J, et al
    Cardiopulmonary exercise test and PaO2 in evaluation of pulmonary hypertension in COPD.
    Int J Chron Obstruct Pulmon Dis. 2017;13:91-100.
    Abstract    

    Abstract available

  104. FERNANDES T, Auger W, Fedullo P
    Epidemiology and risk factors for chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2018 Jan 8. pii: S0049-3848(18)30012.
    Abstract    



  105. AWERBACH JD, Mallory GB Jr, Kim S, Cabrera AG, et al
    Hospital Readmissions in Children with Pulmonary Hypertension: A Multi-Institutional Analysis.
    J Pediatr. 2018 Jan 12. pii: S0022-3476(17)31583.
    Abstract    

    Abstract available

  106. STILL GG, Li S, Wilson M, Sammut P, et al
    Persistent Pulmonary Hypertension Without Underlying Cardiac Disease as a Presentation of Pulmonary Interstitial Glycogenosis.
    Fetal Pediatr Pathol. 2018 Jan 16:1-5. doi: 10.1080/15513815.2017.1397071.
    Abstract    

    Abstract available

  107. WANG WJ, Hong C, Han Q, Gu YY, et al
    Pulmonary Capillary Hemangiomatosis without Pulmonary Hypertension: An Early Stage of Disease?
    Chin Med J (Engl). 2018;131:245-246.
    Abstract    



  108. TAMPAKAKIS E
    In search of markers of pulmonary vascular remodelling in pulmonary hypertension due to left heart disease.
    Eur J Heart Fail. 2018 Jan 15. doi: 10.1002/ejhf.1137.
    Abstract    



  109. SEO YH, Choi HJ
    Clinical Utility of Echocardiography for Early and Late Pulmonary Hypertension in Preterm Infants: Relation with Bronchopulmonary Dysplasia.
    J Cardiovasc Ultrasound. 2017;25:124-130.
    Abstract    

    Abstract available

  110. DRIESSEN MMP, Schings MA, Sieswerda GT, Doevendans PA, et al
    Tricuspid flow and regurgitation in congenital heart disease and pulmonary hypertension: comparison of 4D flow cardiovascular magnetic resonance and echocardiography.
    J Cardiovasc Magn Reson. 2018;20:5.
    Abstract    

    Abstract available

  111. HUSSAIN AS, Ali R, Ahmed S, Naz F, et al
    Oral Sildenafil Use In Neonates With Persistent Pulmonary Hypertension Of Newborn.
    J Ayub Med Coll Abbottabad. 2017;29:677-680.
    Abstract    

    Abstract available

  112. DANIELS SR
    Adverse Outcomes in Pediatric Hypertension.
    Hypertension. 2017 Oct 30. pii: HYPERTENSIONAHA.117.09784.
    Abstract    



  113. RASHID J, Patel B, Nozik-Grayck E, McMurtry IF, et al
    Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).
    J Control Release. 2017;250:96-106.
    Abstract    

    Abstract available

  114. HERESI GA, Malin SK, Barnes JW, Tian L, et al
    Abnormal Glucose Metabolism and High-Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2017;14:190-199.
    Abstract    

    Abstract available

  115. PAGANI-ESTEVEZ GL, Swetz KM, McGoon MD, Frantz RP, et al
    Characterization of Prostacyclin-associated Leg Pain in Patients with Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2017;14:206-212.
    Abstract    

    Abstract available

  116. FOK A, Williams T, McLean CA, Butler E, et al
    Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
    Mult Scler. 2015 Nov 12. pii: 1352458515618020.
    Abstract    

    Abstract available

  117. LI Y, Meng X, Wang Y, Yang Y, et al
    Fibrosing mediastinitis with pulmonary hypertension as a complication of pulmonary vein stenosis: A case report and review of the literature.
    Medicine (Baltimore). 2018;97:e9694.
    Abstract    

    Abstract available

  118. DIAZ-DOMINGUEZ E, Rosas-Peralta M, Santos-Martinez LE, Rodriguez-Almendros NA, et al
    [Obesity hypoventilation syndrome and pulmonary hypertension. An association little-known in Mexico].
    Rev Med Inst Mex Seguro Soc. 2018;56:72-83.
    Abstract    

    Abstract available


  119. "Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice." Stephen Y. Chan and Lewis J. Rubin. Eur Respir Rev 2017; 26: 170094.
    Eur Respir Rev. 2018;27.
    Abstract    



  120. LEGGIO M, Fusco A, Armeni M, D'Emidio S, et al
    Pulmonary Hypertension and Exercise Training: A Synopsis on the More Recent Evidences.
    Ann Med. 2018 Jan 24:1-22. doi: 10.1080/07853890.2018.1432887.
    Abstract    

    Abstract available

  121. MU YP, Huang QH, Zhu JL, Zheng SY, et al
    Magnesium attenuates endothelin-1-induced vasoreactivity and enhances vasodilation in mouse pulmonary arteries: Modulation by chronic hypoxic pulmonary hypertension.
    Exp Physiol. 2018 Jan 23. doi: 10.1113/EP086655.
    Abstract    

    Abstract available

  122. WANG Y, Tian W, Xiu C, Yan M, et al
    Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.
    Clin Rheumatol. 2018 Jan 23. pii: 10.1007/s10067-018-3978.
    Abstract    

    Abstract available

  123. GRYMUZA M, Malaczynska-Rajpold K, Jankiewicz S, Siniawski A, et al
    Right heart catheterization procedures in patients with suspicion of pulmonary hypertension - experiences of a tertiary center.
    Postepy Kardiol Interwencyjnej. 2017;13:295-301.
    Abstract    

    Abstract available

  124. SPENCER L, Zafiropoulos B, Denniss W, Fowler D, et al
    Is there a learning effect when the 6-minute walk test is repeated in people with suspected pulmonary hypertension?
    Chron Respir Dis. 2018 Jan 1:1479972317752762. doi: 10.1177/1479972317752762.
    Abstract    

    Abstract available

  125. REHMAN MB, Garcia R, Christiaens L, Larrieu-Ardilouze E, et al
    Power of resting echocardiographic measurements to classify pulmonary hypertension patients according to European society of cardiology exercise testing risk stratification cut-offs.
    Int J Cardiol. 2018 Jan 17. pii: S0167-5273(17)33293.
    Abstract    

    Abstract available

  126. VON VISGER TT, Kuntz KK, Phillips GS, Yildiz VO, et al
    Quality of life and psychological symptoms in patients with pulmonary hypertension.
    Heart Lung. 2018 Jan 17. pii: S0147-9563(17)30239.
    Abstract    

    Abstract available

  127. LAMBERT M, Boet A, Rucker-Martin C, Mendes-Ferreira P, et al
    Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
    Cardiovasc Res. 2018 Jan 19. pii: 4817464. doi: 10.1093.
    Abstract    

    Abstract available

  128. HOSOKAWA K, Abe K, Horimoto K, Yamasaki Y, et al
    Balloon Pulmonary Angioplasty Relieves Hemodynamic Stress towards Untreated-Side Pulmonary Vasculature and Ameliorates Its Resistance in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    EuroIntervention. 2018 Jan 23. pii: EIJ-D-17-00888. doi: 10.4244/EIJ-D-17-00888.
    Abstract    

    Abstract available

  129. UIKE K, Nagata H, Hirata Y, Yamamura K, et al
    Effective shunt closure for pulmonary hypertension and liver dysfunction in congenital portosystemic venous shunt.
    Pediatr Pulmonol. 2018 Jan 23. doi: 10.1002/ppul.23944.
    Abstract    

    Abstract available

  130. DAYEH NR, Tardif JC, Shi Y, Tanguay M, et al
    Echocardiographic validation of pulmonary hypertension due to heart failure with reduced ejection fraction in mice.
    Sci Rep. 2018;8:1363.
    Abstract    

    Abstract available

  131. IVARSSON B, Hesselstrand R, Radegran G, Kjellstrom B, et al
    Adherence and medication belief in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension- A nationwide population-based cohort survey.
    Clin Respir J. 2018 Jan 22. doi: 10.1111/crj.12770.
    Abstract    

    Abstract available

  132. WANG L, Yang T, Wang C
    Are statins beneficial for the treatment of pulmonary hypertension?
    Chronic Dis Transl Med. 2017;3:213-220.
    Abstract    

    Abstract available

  133. CHEE YY, Wong SCM, Wong MSR
    Rare combination of left-sided congenital diaphragmatic hernia and omphalocele.
    BMJ Case Rep. 2017;2017.
    Abstract    

    Abstract available

  134. GUO S, Shen Y, He G, Wang T, et al
    Involvement of Ca(2+)-activated K(+) channel 3.1 in hypoxia-induced pulmonary arterial hypertension and therapeutic effects of TRAM-34 in rats.
    Biosci Rep. 2017;37.
    Abstract    

    Abstract available

  135. KOCHETKOVA EA, Ugai LG, Maistrovskaia YV, Nevzorova VA, et al
    Adipokines: A Possible Contribution to Vascular and Bone Remodeling in Idiopathic Pulmonary Arterial Hypertension.
    Calcif Tissue Int. 2017;100:325-331.
    Abstract    

    Abstract available

  136. TANAKA S, Shiroto T, Godo S, Saito H, et al
    Important role of endothelium-dependent hyperpolarization in pulmonary microcirculation in male mice -Implications for hypoxia-induced pulmonary hypertension.
    Am J Physiol Heart Circ Physiol. 2018 Jan 5. doi: 10.1152/ajpheart.00487.2017.
    Abstract    

    Abstract available

  137. MARSHALL JD, Bazan I, Zhang Y, Fares WH, et al
    Mitochondrial dysfunction and pulmonary hypertension: Cause, Effect or Both.
    Am J Physiol Lung Cell Mol Physiol. 2018 Jan 18. doi: 10.1152/ajplung.00331.2017
    Abstract    

    Abstract available

  138. DELANEY C, Sherlock L, Fisher S, Maltzahn JK, et al
    Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice.
    Am J Physiol Lung Cell Mol Physiol. 2018 Jan 18. doi: 10.1152/ajplung.00215.2017
    Abstract    

    Abstract available

  139. ZHANG HD, Lv ZC, Wang LT, Rothman A, et al
    Prognostic Significance of Reduced Blood Pressure Response to Exercise in Pediatric Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;196:1478-1481.
    Abstract    



  140. FERNANDES TM, Pretorius VG, Kim NH
    Caution Regarding Catheter-directed Thrombolysis: Chronic Thromboembolic Pulmonary Hypertension Mistaken for Acute Submassive Pulmonary Embolism.
    Am J Respir Crit Care Med. 2017;195:1066-1067.
    Abstract    



  141. LIU D, Yan Y, Chen JW, Yuan P, et al
    Hypermethylation of BMPR2 Promoter Occurs in Patients with Heritable Pulmonary Arterial Hypertension and Inhibits BMPR2 Expression.
    Am J Respir Crit Care Med. 2017;196:925-928.
    Abstract    



  142. NICOLLS MR, Voelkel NF
    The Roles of Immunity in the Prevention and Evolution of Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2017;195:1292-1299.
    Abstract    



  143. PULLAMSETTI SS, Savai R, Seeger W, Goncharova EA, et al
    Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs.
    Am J Respir Crit Care Med. 2017;195:425-437.
    Abstract    



  144. AUSTIN ED, West J, Loyd JE, Hemnes AR, et al
    Translational Advances in the Field of Pulmonary Hypertension Molecular Medicine of Pulmonary Arterial Hypertension. From Population Genetics to Precision Medicine and Gene Editing.
    Am J Respir Crit Care Med. 2017;195:23-31.
    Abstract    



  145. BARMAN SA, Chen F, Li X, Haigh S, et al
    Galectin-3 Promotes Vascular Remodeling and Contributes to Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Jan 24. doi: 10.1164/rccm.201711-2308.
    Abstract    



  146. PRINS KW, Rose L, Archer SL, Pritzker M, et al
    Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Jan 23. doi: 10.1164/rccm.201712-2405.
    Abstract    



  147. ICHINOSE F, Zapol WM
    Inhaled Pulmonary Vasodilators in Cardiac Surgery Patients: Correct Answer Is "NO".
    Anesth Analg. 2017;125:375-377.
    Abstract    



  148. BHATT AM, Stein EJ
    Clinical Complications with the Delivery of Inhaled Epoprostenol in the Operating Room.
    Anesthesiology. 2017;127:383.
    Abstract    



  149. KHOURI C, Lepelley M, Roustit M, Montastruc F, et al
    Comparative safety of drugs targeting the nitric oxide pathway in pulmonary hypertension: a mixed approach combining a meta-analysis of clinical trials and a disproportionality analysis from the WHO pharmacovigilance database.
    Chest. 2017 Dec 21. pii: S0012-3692(17)33265-8. doi: 10.1016/j.chest.2017.
    Abstract    

    Abstract available

  150. FAYYAZ AU, Edwards WD, Maleszewski JJ, Konik EA, et al
    Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated with Heart Failure and Preserved or Reduced Ejection Fraction.
    Circulation. 2017 Dec 15. pii: CIRCULATIONAHA.117.031608.
    Abstract    

    Abstract available

  151. CARUSO P, Dunmore BJ, Schlosser K, Schoors S, et al
    Identification of miR-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 and PKM2.
    Circulation. 2017 Sep 26. pii: CIRCULATIONAHA.117.028034.
    Abstract    

    Abstract available

  152. CHATTERJEE K, Tarawneh AR, Alam S
    Out of proportion pulmonary hypertension in obstructive lung diseases.
    Curr Opin Pulm Med. 2017 Dec 18. doi: 10.1097/MCP.0000000000000457.
    Abstract    

    Abstract available

  153. TRAMPER J, Nossent EJ, Lely RJ, Krouwels FH, et al
    Balloon pulmonary angioplasty in sarcoid-related pulmonary hypertension.
    Eur Respir J. 2018;51.
    Abstract    



  154. COTTIN V, Price LC, Valenzuela C
    The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis.
    Eur Respir J. 2018;51.
    Abstract    



  155. KUMAR R, Graham B
    How does inflammation contribute to pulmonary hypertension?
    Eur Respir J. 2018;51.
    Abstract    



  156. KRIECHBAUM SD, Wiedenroth CB, Wolter JS, Hutz R, et al
    N-terminal pro-B-type natriuretic peptide for monitoring after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2017 Dec 8. pii: S1053-2498(17)32145.
    Abstract    

    Abstract available

  157. DIAMOND JM, Ramphal K, Porteous MK, Cantu E 3rd, et al
    Association of long pentraxin-3 with pulmonary hypertension and primary graft dysfunction in lung transplant recipients.
    J Heart Lung Transplant. 2017 Dec 20. pii: S1053-2498(17)32189.
    Abstract    



  158. ROAN JN, Hsu CH, Fang SY, Tsai HW, et al
    Exendin-4 improves cardiovascular function and survival in flow-induced pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2017 Nov 7. pii: S0022-5223(17)32432.
    Abstract    

    Abstract available

  159. FUJIMOTO Y, Minamisawa S
    Elusive mechanisms responsible for pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2018;155:282.
    Abstract    



  160. KATZ MG, Fargnoli AS, Hajjar RJ, Hadri L, et al
    Pulmonary hypertension arising from left heart disease causes intrapulmonary venous arterialization in rats.
    J Thorac Cardiovasc Surg. 2018;155:281-282.
    Abstract    




Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;